ICD-10-CM Billable Code

E71.3

Disorders of fatty-acid metabolism

Clinical Classification Guidelines

Excludes Type 1

  • peroxisomal disorders (E71.5)
  • Refsum's disease (G60.1)
  • Schilder's disease (G37.0)

Excludes Type 2

  • carnitine deficiency due to inborn error of metabolism (E71.42)

Medical Intelligence & Overview

Disorders of fatty acid metabolism are a group of rare genetic conditions that affect the body's ability to break down and utilize fats for energy. When these processes are impaired, it can lead to a buildup of fatty acids or their derivatives in the body, which may cause a variety of health issues. These conditions are classified under ICD-10 code E71.3 and require careful management to prevent complications. Understanding these disorders can help in recognizing symptoms early and seeking appropriate medical follow-up.

Causes & Symptoms

Clinical Causes: Inherited genetic mutations affecting enzymes involved in fatty acid breakdown Deficiencies in specific enzymes necessary for fatty acid oxidation Mutations affecting proteins responsible for transporting fatty acids into cell mitochondria Rare metabolic syndromes that disrupt normal fatty acid processing

Key Symptoms: Episodes of hypoglycemia (low blood sugar), especially during fasting or illness Muscle weakness or pain, particularly during exercise Learning difficulties or developmental delays in some cases Lethargy and fatigue Difficulty tolerating fasting Hepatomegaly (enlarged liver) Unusual smell or odor in urine or sweat due to unmetabolized fatty acids Signs of metabolic crisis such as vomiting, breathing difficulties, or coma during episodes

Diagnostic & Treatment

Diagnosis Path: Diagnosing fatty acid metabolism disorders typically involves a combination of clinical evaluation and specialized laboratory tests. Blood and urine analyses can detect abnormal levels of fatty acids or alternative metabolites indicative of metabolic disruption. Confirmatory testing often includes genetic analysis to identify specific mutations. Additionally, enzyme activity assays can help determine which part of the fatty acid oxidation pathway is impaired. Healthcare providers may also recommend fasting tests under supervision to observe abnormal metabolic responses.

Treatment Protocols: Dietary modifications: Implementing a low-fat, high-carbohydrate diet to reduce reliance on fatty acid oxidation Avoiding fasting periods: Regular, timed meals to maintain stable blood sugar levels Supplementation: Use of medium-chain triglycerides (MCTs) which can be easier to metabolize Emergency protocols: Having plans and medications ready for metabolic stress or crisis Monitoring: Regular follow-up with healthcare providers for assessment and adjustment of treatment plan Genetic counseling: To inform affected families about inheritance patterns and future planning

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E71.3 a billable ICD-10 code?
Yes, E71.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E71.3?
Clinical documentation must specify the nature of Disorders of fatty-acid metabolism and any associated comorbidities for accurate reporting.

Cite this Clinical Reference